Avalo Therapeutics
AVTX
AVTX
52 hedge funds and large institutions have $113M invested in Avalo Therapeutics in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
11% less capital invested
Capital invested by funds: $127M → $113M (-$13.9M)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
Holders
52
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.63M | |
| 2 | +$897K | |
| 3 | +$755K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$610K |
| 5 |
BlackRock
New York
|
+$564K |
Top Sellers
| 1 | -$1.17M | |
| 2 | -$827K | |
| 3 | -$647K | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$460K |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$300K |